EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and Staphylococcus aureus

Mairéad Gallagher, Lyuboslava G Harkova, Dominika Krawiel, Ronan R McCarthy, Gordon Cooke, Fintan Kelleher

Journal of Global Antimicrobial Resistance · 2026

DOI: 10.1016/j.jgar.2026.07.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Global Antimicrobial Resistance, 2026. Verfasst von Mairéad Gallagher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for AMR and One Health Research, TU Dublin Tallaght Campus, Dublin, Ireland. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Ciprofloxacin, Staphylococcus aureus. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council, Environmental Protection Agency, Irish Research Council for Science Engineering and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate how two major ciprofloxacin metabolites, 2-oxo ciprofloxacin (M3) and N-formyl ciprofloxacin (M4), influence the resistance profiles and biofilm characteristics of Pseudomonas aeruginosa (PAO1) and Staphylococcus aureus (ATCC 25923). METHODS: Both metabolites were synthesised, structurally validated, and co-cultured with bacterial strains at subinhibitory concentrations over a 30-d period. Minimum inhibitory concentration (MIC) assays, crystal violet biofilm quantification, and genomic and transcriptomic analyses (whole-genome and differential RNA sequencing) were employed to assess phenotypic and molecular adaptations. RESULTS: Exposure to ciprofloxacin metabolites altered bacterial behaviour despite their weak intrinsic antimicrobial activity. In S. aureus, continuous exposure to M3 and M4 resulted in an eight- and fourfold increase, respectively, in ciprofloxacin MIC values. In P. aeruginosa, although MIC values remained unchanged, prolonged exposure to both metabolites enhanced biofilm formation, M4 (P < 0.0001) and M3 (P < 0.0089). Genomic sequencing of P. aeruginosa revealed a missense mutation (A290D) in the wspA gene following M3 exposure, which activates biofilm-promoting pathways via cyclic-di-GMP signalling. RNA sequencing identified 220 differentially expressed genes, including upregulation of quorum-sensing regulators (rhlI, pqsH), nitric oxide cycle genes (nir, norCB), and the pel operon. CONCLUSIONS: Ciprofloxacin metabolites, though less potent than the parent antibiotic, can drive adaptive responses linked to resistance and persistence. Their capacity to induce stable genetic and transcriptomic shifts underscores their potential ecological and clinical significance as underexplored factors in antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPseudomonas aeruginosaCiprofloxacinStaphylococcus aureusAnti-Bacterial AgentsDrug Resistance, BacterialMicrobial Sensitivity TestsGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

AMRAntibiotic metabolitesBiofilmsCiprofloxacinPseudomonas aeruginosaStaphylococcus aureus

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Centre for AMR and One Health Research, TU Dublin Tallaght Campus, Dublin, Ireland.
  • School of Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Antimicro…
  • Centre for AMR and One Health Research, TU Dublin Tallaght Campus, Dublin, Ireland. Electronic address: gordon.cooke@tudublin.ie.
  • Centre for AMR and One Health Research, TU Dublin Tallaght Campus, Dublin, Ireland. Electronic address: fintan.kelleher@tudublin.ie.

Förderung

  • UK Research and Innovation Medical Research Council
  • Environmental Protection Agency
  • Irish Research Council for Science Engineering and Technology

Zitieren

APA

Gallagher, M., Harkova, L. G., Krawiel, D., McCarthy, R. R., Cooke, G., & Kelleher, F. (2026). Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and Staphylococcus aureus. Journal of Global Antimicrobial Resistance. https://doi.org/10.1016/j.jgar.2026.07.024

Vancouver

Gallagher M, Harkova LG, Krawiel D, McCarthy RR, Cooke G, Kelleher F. Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and Staphylococcus aureus. Journal of Global Antimicrobial Resistance. 2026. doi:10.1016/j.jgar.2026.07.024

BibTeX
@article{Gallagher2026,
  author = {Gallagher, Mairéad and Harkova, Lyuboslava G and Krawiel, Dominika and McCarthy, Ronan R and Cooke, Gordon and Kelleher, Fintan},
  title = {Ciprofloxacin metabolites drive resistance development and biofilm changes in Pseudomonas aeruginosa and Staphylococcus aureus},
  journal = {Journal of Global Antimicrobial Resistance},
  year = {2026},
  doi = {10.1016/j.jgar.2026.07.024}
}
Kostenlos starten →